IRIS
PIZZIGALLO, Eligio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.151
EU - Europa 4.259
AS - Asia 4.109
SA - Sud America 791
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 5
Totale 14.379
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.066
SG - Singapore 1.500
CN - Cina 1.362
UA - Ucraina 946
IE - Irlanda 688
BR - Brasile 655
GB - Regno Unito 639
TR - Turchia 609
FR - Francia 424
SE - Svezia 419
DE - Germania 365
IT - Italia 313
VN - Vietnam 275
FI - Finlandia 197
IN - India 173
RU - Federazione Russa 142
AR - Argentina 66
CA - Canada 48
ID - Indonesia 28
BD - Bangladesh 26
MX - Messico 25
PL - Polonia 22
KR - Corea 21
ZA - Sudafrica 21
AT - Austria 20
CZ - Repubblica Ceca 20
ES - Italia 19
EC - Ecuador 18
IQ - Iraq 17
HK - Hong Kong 15
PK - Pakistan 12
BE - Belgio 11
VE - Venezuela 11
CL - Cile 10
CO - Colombia 10
EU - Europa 10
JP - Giappone 10
IL - Israele 9
PY - Paraguay 9
UZ - Uzbekistan 9
LT - Lituania 8
MA - Marocco 8
NL - Olanda 7
TN - Tunisia 7
EG - Egitto 6
GR - Grecia 6
IR - Iran 6
PE - Perù 6
SA - Arabia Saudita 6
MY - Malesia 5
AU - Australia 4
BG - Bulgaria 4
KE - Kenya 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
JO - Giordania 3
NP - Nepal 3
SC - Seychelles 3
BB - Barbados 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
LB - Libano 2
OM - Oman 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.379
Salva come PNG Salva come JPEG
Città #
Singapore 1.145
Jacksonville 1.034
Dublin 687
Chandler 580
Southend 557
Princeton 351
Izmir 340
Nanjing 321
Dallas 310
Beijing 265
Wilmington 191
Ashburn 175
Cambridge 171
Santa Clara 150
Tongling 143
The Dalles 132
Los Angeles 129
Nanchang 119
Dearborn 114
Buffalo 103
Ho Chi Minh City 103
Altamura 99
Ann Arbor 76
Boardman 62
São Paulo 61
Kunming 58
Munich 58
Woodbridge 57
Shenyang 54
Grevenbroich 52
Hanoi 51
Moscow 49
Tianjin 42
Hebei 41
Jiaxing 35
Council Bluffs 33
New York 28
Pune 28
Toronto 28
Changsha 26
Norwalk 26
Hangzhou 24
Chieti 22
Houston 21
Lanzhou 21
Augusta 20
Seoul 20
Brno 18
San Mateo 18
Brooklyn 17
Hefei 16
Helsinki 16
Rio de Janeiro 16
Denver 15
Hong Kong 15
Chicago 14
Redondo Beach 14
Belo Horizonte 13
Haiphong 13
London 13
Rome 13
Andover 12
Jinan 12
Nuremberg 12
Turku 12
Vienna 12
Atlanta 11
Brussels 11
Changchun 11
Curitiba 11
Da Nang 11
Phoenix 11
Recife 11
San Francisco 11
Stockholm 11
Warsaw 11
Tokyo 10
Biên Hòa 9
Brasília 9
Fortaleza 9
Johannesburg 9
Mexico City 9
Montreal 9
Orange 9
Radomsko 9
Salvador 9
Seattle 9
Tashkent 9
Washington 9
Boston 8
Campinas 8
Caxias do Sul 8
Dhaka 8
Dong Ket 7
Falls Church 7
Leawood 7
Maceió 7
Ningbo 7
Asunción 6
Auburn Hills 6
Totale 8.790
Salva come PNG Salva come JPEG
Nome #
Caso clinico di endoplastite da Staphylococcus capitis. 162
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 150
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 142
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 139
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 137
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 132
Metabolic modifications in HIV-infected women 129
Acute urinary retention due to HSV-1: a case report 126
Ricerche sull'autoimmunità in alcune epatopatie. 124
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 123
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 123
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 122
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 121
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 121
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 117
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 114
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 114
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 112
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 111
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 111
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 110
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 109
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 108
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 108
Inguinal lymphadenopathy due to Bartonella henselae 106
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 106
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 105
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 105
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 105
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 103
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 102
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 102
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 102
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 102
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 101
Interruption of highly active antiretroviral therpy in HIV clinical practice. 101
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 101
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 100
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 99
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 98
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 98
Hepatitis C virus infection and myositis: a virus localization study. 98
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 98
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 98
The association of chronic hepatitis B and myopathy 97
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 97
Le associazioni di antibiotici: aspetti clinici. 97
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 97
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 97
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 97
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 96
Proteinuria in an African HIV-infected patient: effects of telmisartan. 96
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 96
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 96
Ocular manifestations in chronic fatigue syndrome. 96
An unusual complication of brucellosis: hepatic abscess. 95
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 95
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 94
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 94
Research on a new hepatitis B antigen-antibody system: e- anti-e. 92
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 92
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 92
High dose of erythropoietin in management of interferon/ribavirin induced anemia 91
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 90
Patient-reported and Physician-estimated Adherence to HAART. 90
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 89
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 87
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 86
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 86
Attualità sulle infezioni batteriche del SNC. 85
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 85
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 85
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 85
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 84
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 83
Chronic fatigue syndrome following a toxic exposure. 83
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 83
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 83
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 83
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 83
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing. 81
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 79
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART. 79
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 78
An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences 78
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 77
Ricerche su donatori di sangue Au-positivi: stimolazione in vitro dei linfociti con PHA. 77
Comparative analysis of two systems for HCV genotyping. 76
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. 76
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 76
Significato clinico dell'antigene “e” e dell'anticorpo anti “e” determinati con il metodo radioimmunologico. 75
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 75
Modelling the 3-year risk of myocardial infarction among participants in the data collection on adverse events of anti-HIV drugs (DAD) study. 75
Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non nucleoside reverse transcriptase inhibitor-containing regimens. 75
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 75
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 74
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 74
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 74
Clinical and Pathophysiological Aspects of Chronic Fatigue Syndrome 74
Genetic polymorphisms differently influencing the emergence of atrophy and far accumulation in HIV-related lipodystrophy. 74
Totale 9.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021520 0 0 0 0 0 197 8 6 83 179 12 35
2021/2022597 7 3 5 103 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/20252.757 216 579 468 33 21 48 7 145 228 138 270 604
2025/20262.564 409 296 691 789 321 58 0 0 0 0 0 0
Totale 14.605